A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00293891

Enrollment

658

Registered

2006-02-20

Start date

Unknown

Completion date

2007-01-31

Last updated

2007-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Keywords

Treatment Outcome, Tacrolimus, Safety, Psoriasis

Brief summary

A study to assess the safety and effectiveness of tacrolimus cream in the treatment of psoriasis.

Interventions

DRUGTacrolimus Cream

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

12 Years to No maximum

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of plaque psoriasis

Exclusion criteria

* Skin disorder other than plaque psoriasis in the areas to be treated. * Disease on only elbows, knees, and scalp

Countries

Canada, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026